Esophageal Carcinoma — Trials

Esophageal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

807 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 307
Recruiting: 179
Ph III recruiting: 26
Growth YoY: +33.8%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (62)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06420908	Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)	withdrawn	N/A	0	Hebei Medical University Fourth HospitalOTHER	0	Aug 26, 2025	clinicaltrials
NCT05001360	Study of FMT Combined With Nivolumab in Gastric Cancer	withdrawn	N/A	0	Fujian Cancer HospitalOTHER_GOV	1	Oct 27, 2021	clinicaltrials